BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND STAT3, FLJ20882, 6774, ENSG00000168610, APRF, P40763, MGC16063 AND Prognosis
137 results:

  • 1. Glycolysis and tumor progression promoted by the m
    Yang K; Zhong Z; Zou J; Liao JY; Chen S; Zhou S; Zhao Y; Li J; Yin D; Huang K; Li Y
    Cancer Lett; 2024 May; 590():216840. PubMed ID: 38604311
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Fundamental insights and molecular interactions in pancreatic cancer: Pathways to therapeutic approaches.
    Gu M; Liu Y; Xin P; Guo W; Zhao Z; Yang X; Ma R; Jiao T; Zheng W
    Cancer Lett; 2024 Apr; 588():216738. PubMed ID: 38401887
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Corosolic acid enhances oxidative stress-induced apoptosis and senescence in pancreatic cancer cells by inhibiting the JAK2/stat3 pathway.
    Luo X; Ye Z; Xu C; Chen H; Dai S; Chen W; Bao G
    Mol Biol Rep; 2024 Jan; 51(1):176. PubMed ID: 38252208
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. ANGPTL4 accelerates ovarian serous cystadenocarcinoma carcinogenesis and angiogenesis in the tumor microenvironment by activating the JAK2/stat3 pathway and interacting with ESM1.
    Li YK; Gao AB; Zeng T; Liu D; Zhang QF; Ran XM; Tang ZZ; Li Y; Liu J; Zhang T; Shi GQ; Zhou WC; Zou WD; Peng J; Zhang J; Li H; Zou J
    J Transl Med; 2024 Jan; 22(1):46. PubMed ID: 38212795
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. IL20RB signaling enhances stemness and chemotherapy resistance in pancreatic cancer.
    Li XH; Huang GZ; Xu ZL; Zhao CY; Dong XY; Cui BK; Lin XJ
    J Transl Med; 2023 Dec; 21(1):911. PubMed ID: 38098005
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. AUF1-induced circular RNA hsa_circ_0010467 promotes platinum resistance of ovarian cancer through miR-637/LIF/stat3 axis.
    Wu Y; Xu M; Feng Z; Wu H; Wu J; Ha X; Wu Y; Chen S; Xu F; Wen H; Li S; Wu X
    Cell Mol Life Sci; 2023 Aug; 80(9):256. PubMed ID: 37589744
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. stat3 inhibition enhances gemcitabine sensitivity in pancreatic cancer by suppressing EMT, immune escape and inducing oxidative stress damage.
    Guo H; Hu Z; Yang X; Yuan Z; Gao Y; Chen J; Xie L; Chen C; Guo Y; Bai Y
    Int Immunopharmacol; 2023 Oct; 123():110709. PubMed ID: 37515849
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Anisomycin inhibits the activity of human ovarian cancer stem cells via regulating antisense RNA NCBP2-AS2/MEK/ERK/stat3 signaling.
    Ling L; Wen Y; Xiong Y; Liu X; Chen J; Liu T; Zhang B
    J Gene Med; 2024 Jan; 26(1):e3571. PubMed ID: 37483091
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. TMPOP2 Inhibition Suppresses Pancreatic cancer Cell Migration and Development by Repressing The JNK/stat3 Pathway.
    Liang J; Cao H; Wang G; Wei L; Dong L; Chen G; Li Q; Zhu D
    Adv Biol (Weinh); 2023 Dec; 7(12):e2300113. PubMed ID: 37469237
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Molecular profile of metastasis, cell plasticity and EMT in pancreatic cancer: a pre-clinical connection to aggressiveness and drug resistance.
    Guo Z; Ashrafizadeh M; Zhang W; Zou R; Sethi G; Zhang X
    Cancer Metastasis Rev; 2024 Mar; 43(1):29-53. PubMed ID: 37453022
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesis.
    Huang C; Li H; Xu Y; Xu C; Sun H; Li Z; Ge Y; Wang H; Zhao T; Gao S; Wang X; Yang S; Sun P; Liu Z; Liu J; Chang A; Hao J
    Signal Transduct Target Ther; 2023 Jul; 8(1):271. PubMed ID: 37443111
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. CD109 Promotes Drug Resistance in A2780 Ovarian cancer Cells by Regulating the stat3-NOTCH1 Signaling Axis.
    Kim JS; Shin MJ; Lee SY; Kim DK; Choi KU; Suh DS; Kim D; Kim JH
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373457
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Adipocytes promote pancreatic cancer migration and invasion through fatty acid metabolic reprogramming.
    Cai Z; Li Y; Ma M; Wang L; Wang H; Liu M; Jiang C
    Oncol Rep; 2023 Jul; 50(1):. PubMed ID: 37264956
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Systemic Alterations in Type-2 Conventional Dendritic Cells Lead to Impaired Tumor Immunity in Pancreatic cancer.
    James CA; Baer JM; Zou C; Panni UY; Knolhoff BL; Hogg GD; Kingston NL; Kang LI; Lander VE; Luo J; Tao Y; Watson MA; Aft R; Fields RC; Hawkins WG; DeNardo DG
    Cancer Immunol Res; 2023 Aug; 11(8):1055-1067. PubMed ID: 37229629
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [Signal transducer and activator of transcription 3 and cancer associated fibroblasts jointly generate chemo-resistance and affect prognosis in epithelial ovarian cancer].
    Zhang YN; Li B; Li YQ; Liu SH; Hou HY; Wang KY; Ao M; Song Y
    Zhonghua Fu Chan Ke Za Zhi; 2023 May; 58(5):368-377. PubMed ID: 37217344
    [No Abstract]    [Full Text] [Related]  

  • 16. Protein tyrosine phosphatase nonreceptor type 2 exerts antimetastatic functions in pancreatic ductal adenocarcinoma.
    Zhang S; Wang H; Mao P; Sun Q; Su H; Zhang Y; Shen S; Xu G; Wang L; Zou X; Zhan Q; Lv Y
    Mol Carcinog; 2023 Aug; 62(8):1176-1190. PubMed ID: 37204217
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. A novel immune checkpoint score system for prognostic evaluation in pancreatic adenocarcinoma.
    Chen Y; Lin X; Zou X; Qian Y; Liu Y; Wang R; Wang X; Yu X; Liu C; Cheng H
    BMC Gastroenterol; 2023 Apr; 23(1):113. PubMed ID: 37024802
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. stat3 signaling in pancreatic ductal adenocarcinoma: a candidate therapeutic target.
    Al-Hetty HRAK; Abdulameer SJ; Alkubaisy SA; Zaid SA; Jalil AT; Jasim IK
    Pathol Res Pract; 2023 May; 245():154425. PubMed ID: 37019018
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Bisphenol A disruption promotes mammary tumor microenvironment via phenotypic cell polarization and inflammatory response.
    Ruiz TFR; Colleta SJ; Dos Santos DD; Castro NFC; Cabral ÁS; Calmon MF; Rahal P; Gil CD; Girol AP; Vilamaior PSL; Leonel ECR; Taboga SR
    Cell Biol Int; 2023 Jun; 47(6):1136-1146. PubMed ID: 36906806
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Systematic analysis of the BET family in adrenocortical carcinoma: The expression, prognosis, gene regulation network, and regulation targets.
    Situ Y; Liang Q; Zeng Z; Chen J; Shao Z; Xu Q; Lu X; Cui Y; Zhang J; Lu L; Deng L
    Front Endocrinol (Lausanne); 2023; 14():1089531. PubMed ID: 36793283
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 7.